4.7 Article

A new biodegradable crosslinked polyethylene oxide sulfide (PEOS) hydrogel for controlled drug release

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 374, 期 1-2, 页码 58-65

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2009.03.010

关键词

Hydrogel; PEG; Disulfide; Biodegradable; DDS

资金

  1. Korea Healthcare technology RD Project
  2. Ministry for Health, Welfare and Family Affairs, Republic of Korea [A084285]
  3. Ministry of Science and Technology [M10534030004-08N3403-00410]
  4. Korea Health Promotion Institute [A084285] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  5. National Research Foundation of Korea [과06A1501, 2005-2001099] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

We developed a polyethylene glycol (PEG)-based biodegradable hydrogel through disulfide crosslinking of polyethylene oxide sulfide (PEOS). The crosslinking rate was highly dependent on temperature, and incubation at about 40-50 degrees C was required for efficient crosslinking. The crosslinked PEOS hydrogel showed glutathione-dependent dissolution and corresponding controlled release of a model drug-fluorescein isothiocyanate (FITC)-labeled dextran-because the disulfide bond, the main linker, is selectively degraded in response to the high concentration of glutathione. The temperature-sensitive crosslinking and the hydrogel formation have the potential for use as an injectable biogel precursor, which was confirmed by in situ gel formation in mice. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据